Literature DB >> 24479644

Living with the unexplained: coping, distress, and depression among women with chronic fatigue syndrome and/or fibromyalgia compared to an autoimmune disorder.

Opal A McInnis1, Kimberly Matheson, Hymie Anisman.   

Abstract

Chronic fatigue syndrome (CFS) and fibromyalgia are disabling conditions without objective diagnostic tests, clear-cut treatments, or established etiologies. Those with the disorders are viewed suspiciously, and claims of malingering are common, thus promoting further distress. It was hypothesized in the current study that levels of unsupportive social interactions and the coping styles used among those with CFS/fibromyalgia would be associated with perceived distress and depressive symptoms. Women with CFS/fibromyalgia (n=39), in fact, reported higher depression scores, greater perceived distress and more frequent unsupportive relationships than healthy women (n=55), whereas those with a chronic, but medically accepted illness comprising an autoimmune disorder (lupus erythematosus, multiple sclerosis, rheumatoid arthritis; n=28), displayed intermediate scores. High problem-focused coping was associated with low levels of depression and perceived distress in those with an autoimmune condition. In contrast, although CFS/fibromyalgia was also accompanied by higher depression scores and higher perceived distress, this occurred irrespective of problem-focused coping. It is suggested that because the veracity of ambiguous illnesses is often questioned, this might represent a potent stressor in women with such illnesses, and even coping methods typically thought to be useful in other conditions, are not associated with diminished distress among those with CFS/fibromyalgia.

Entities:  

Keywords:  chronic illness; depressive symptoms; perceived stress; unsupportive social interactions

Mesh:

Year:  2014        PMID: 24479644     DOI: 10.1080/10615806.2014.888060

Source DB:  PubMed          Journal:  Anxiety Stress Coping        ISSN: 1061-5806


  19 in total

1.  Selective serotonin reuptake inhibitor combined with dengzhanshengmai capsule improves the fatigue symptoms: a 12-week open-label pilot study.

Authors:  De-Qiang Li; Zhong-Chun Li; Zhi-Yuan Dai
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies.

Authors:  Gislaine Z Réus; Karen Jansen; Stephanie Titus; André F Carvalho; Vilma Gabbay; João Quevedo
Journal:  J Psychiatr Res       Date:  2015-05-19       Impact factor: 4.791

3.  Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.

Authors:  Stephanie L McManimen; Andrew R Devendorf; Abigail A Brown; Billie C Moore; James H Moore; Leonard A Jason
Journal:  Fatigue       Date:  2016-10-12

4.  Coping, uncertainty and health-related quality of life as determinants of anxiety and depression on a sample of hospitalized cardiac patients in Southern Italy.

Authors:  Maria Daniela Giammanco; Lara Gitto
Journal:  Qual Life Res       Date:  2016-05-31       Impact factor: 4.147

5.  Early-Life Social Isolation-Induced Depressive-Like Behavior in Rats Results in Microglial Activation and Neuronal Histone Methylation that Are Mitigated by Minocycline.

Authors:  Hong-Tao Wang; Fu-Lian Huang; Zhao-Lan Hu; Wen-Juan Zhang; Xiao-Qing Qiao; Yan-Qing Huang; Ru-Ping Dai; Fang Li; Chang-Qi Li
Journal:  Neurotox Res       Date:  2017-01-16       Impact factor: 3.911

Review 6.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

7.  Psychometric Evaluation of the Patient-Reported Outcomes Measurement Information System Fatigue-Short Form Across Diverse Populations.

Authors:  Suzanne Ameringer; R K Elswick; Victoria Menzies; Jo Lynne Robins; Angela Starkweather; Jeanne Walter; Amanda Elswick Gentry; Nancy Jallo
Journal:  Nurs Res       Date:  2016 Jul-Aug       Impact factor: 2.381

8.  Personal resource profiles of individuals with chronic pain: Sociodemographic and pain interference differences.

Authors:  Chung Jung Mun; Mary C Davis; Ivan R Molton; Paul Karoly; Hye Won Suk; Dawn M Ehde; Howard Tennen; Robert D Kerns; Mark P Jensen
Journal:  Rehabil Psychol       Date:  2019-01-28

9.  Catastrophizing, Acceptance, and Coping as Mediators Between Pain and Emotional Distress and Disability in Fibromyalgia.

Authors:  María J Lami; M Pilar Martínez; Elena Miró; Ana I Sánchez; Manuel A Guzmán
Journal:  J Clin Psychol Med Settings       Date:  2018-03

Review 10.  IDO and TDO as a potential therapeutic target in different types of depression.

Authors:  Yanjie Qin; Nanxi Wang; Xinlin Zhang; Xuemei Han; Xuejia Zhai; Yongning Lu
Journal:  Metab Brain Dis       Date:  2018-07-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.